Pfizer Sells $700M Stake in Haleon, Trimming Ownership to 7.3%
1 day ago · Once complete, Pfizer's stake in Haleon will fall from 15.0% to around 7.3%. Pfizer's move comes after Haleon's spin-off as an independent consumer healthcare company, part of plans to reshape its ...
Why Pfizer sold its $3 billion stake in Haleon - MSN
Pfizer’s decision to offload $3.05 billion worth of shares in Haleon is a strategic move driven by shifting priorities in a volatile pharmaceutical market. The transaction, involving 700 million ...
Pfizer to sell $3 billion stake in Sensodyne maker Haleon - MSN
The sale of 700 million Haleon shares at 357 pence apiece is a discount of about 2.8% to the stock's closing price on Tuesday. ... Pfizer, which will remain Haleon's largest shareholder after the ...
Pfizer Further Pares Haleon Stake With £2.5 Billion Sale - Yahoo …
3 days ago · Pfizer sold shares of Haleon last year, including a £2.4 billion overnight sale in the autumn. Haleon was formed in 2022 from a combination of GSK Plc and Pfizer’s consumer-health units.
Pfizer Sells 700 Million Haleon Shares for $3.05 Billion
Pfizer PFE1.03%increase; green up pointing triangle has sold 700 million shares in British consumer-healthcare business Haleon HLN-0.24%decrease; red down pointing triangle for 2.50 billion pounds ...
Pfizer Provides Update on Ownership Interest in Haleon
Jun 1, 2022 · However, in keeping with Pfizer’s transformation into a more focused, global leader in science-based innovative medicines and vaccines, the company intends to exit its 32% ownership interest in Haleon in a disciplined manner, with the objective of maximizing value for Pfizer shareholders.
Pfizer Further Pares Haleon Stake With £2.5 Billion Sale (2)
3 days ago · Pfizer Inc. sold about 700 million shares in Haleon Plc, representing a roughly 7.7% stake in the maker of Sensodyne toothpaste. The deal raised around £2.5 billion ($3.1 billion) for the seller, which offered the shares through an accelerated placement with investors, according to terms seen by Bloomberg.
Pfizer to sell $3 billion stake in Sensodyne maker Haleon
3 days ago · Pfizer will sell shares worth 2.50 billion pounds ($3.05 billion) in Haleon , lowering its stake in the British consumer healthcare company to about 7.3% from 15%, its bookrunner JPMorgan said on ...
Drug giant Pfizer sells $3.3 bln stake in Sensodyne-maker Haleon
Sep 30, 2024 · Pfizer sold a stake in British consumer healthcare group Haleon worth about $3.26 billion on Monday, cutting its shareholding in the maker of Sensodyne toothpaste and Panadol and Advil...
Pfizer to cut stake in Sensodyne toothpaste-maker Haleon to 24%
Mar 18, 2024 · Consumer healthcare firm Haleon said on Monday that U.S. drugmaker Pfizer , its top shareholder, will sell down its stake in the company to about 24%.
- Some results have been removed